# Pioglitazone

NDC: 0093-7271
Generic name: Pioglitazone
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20150204

FDA application: ANDA077210

## Active ingredients

- PIOGLITAZONE HYDROCHLORIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-7271"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-7271
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5c81c67-90cf-4e64-acb5-58b0358fa742